Global Dental Collagen Membranes Market 2026 – 2035

The size of the global dental collagen membranes market is estimated at USD 0.43 billion in 2025 and it is estimated to grow at a CAGR of 7.1% between 2026 and 2035 with 2026 market being USD 0.46 billion and the 2035 market estimated at USD 0.86 billion.

The growing popularity of periodontal diseases in the world, increasing instances of dental implant, aging population who are at risk of losing teeth, solid clinical data on the effectiveness of collagen membranes, and technological innovations in the manufacturing of biomaterials are the factors that will see the market develop.

Market Highlight

• North America led the dental collagen membranes market with a market share of 38% in 2025.

• Asia Pacific is estimated to grow at a CAGR of 8.2% between the years 2026 and 2035.

• By source, the bovine collagen fragment that was taken in 2025 was capturing about 62% of the market share.

• By type, the resorbable membranes segment is increasing at the highest CAGR of 7.8% between the years 2026 and 2035.

• Application Guided bone regeneration segment had the largest market share of 44% in 2025 with the ridge preservation segment projected to have the quickest CAGR of 8.6% over the estimated time span between 2026 and 2035.

• By end-user, the dental clinics segment had taken over 56% market share in 2025.

• Dental collagen membrane holds a dominant share of 68.5% of the overall barrier membrane market in the 2024 market.

Significant Growth Factors

The Dental Collagen Membranes Market Trends present significant growth opportunities due to several factors:

• Surging Dental Implant Procedures and Periodontal Disease Prevalence Globally:

The growing popularity of dental implant surgeries and escalating periodontal disease burden in the global world are the main forces behind the dental collagen membrane market, and regenerative procedures need effective barrier materials within which collagen membrane is an efficient source of successful results. Global dental health analysis in 2025 indicates that about 3 million dental implants will be placed a year in the United States alone and the global market of dental implants is projected to hit USD 10.48 billion by 2030, which will be a significant source of demand in collagen membranes that are used in guided bone regeneration procedures. According to the World Health Organization, a severe periodontal disease occurs in about 19% of the total adult population in the world, which is over 1 billion cases and the prevalence was 1.07 billion in 2021 as per the Global Burden of Disease Study data.

Periodontal diseases are the 11th most common disease in the world and their regenerative therapies in which collagen membranes are vital are experiencing mammoth demand. With the increasing age of the population and oral health consciousness, there is an increasing number of patients seeking complex dental therapies such as implant-supported restorations, bridges, and periodontal regeneration therapy that need collagen membrane barriers. The use of dental collagen membrane is an important biosurgical barrier used in guided bone regeneration (GBR) and guided tissue regeneration (GTR) surgeries to prevent advancements of soft tissues within bone cavities and provide the undifferentiated mesenchymal cells the opportunity to differentiate into osteoblasts required to form bone appropriately.

The U.S. alone is estimated to have 3 million dental implant persons with 500,000 more annually and dental implant procedures normally demand bone grafting to produce a stable location, which creates a direct pull in collagen membranes over grafts and regeneration. The industry estimates the world market in dental implants and prosthetics to reach USD 18.79 billion by 2030 compared to USD 12.57 billion in 2025, which is an unmatched demand for supporting biomaterials such as collagen membranes.

The contemporary collagen membranes are biocompatible, have predictable resorption that removes the need to use a second surgery to remove the membrane, and are easy to handle in the implantation process and they also integrate well with the surrounding tissues, which is why the collagen membranes are preferable to the synthetic ones. The resorbable nature of the membranes is a major boost to patient satisfaction since it avoids an additional removal surgery that will reduce the level of comfort, incur high costs, and cause other possible complications such as infection or tissue degradation.

• Growing Geriatric Population and Rising Tooth Loss Incidence:

The market has expanded immensely owing to the increasing rates of tooth loss among the elderly in the world, who have increased rates of edentulism and periodontal disease that need regenerative dental intervention by supporting collagen membranes. The Population reference bureau forecasts that by 2050, the population of persons 65 and above in the United States will grow by 41%, from 58 million people of this age group in 2022 to 82 million people of this age group in 2050. About 23% of senior citizens all over the world have lost all their teeth, and loss of teeth is still a challenge of aging notwithstanding the advancement of dental treatment. It is estimated that 178 million Americans are lacking at least one tooth, all of whom are potential patients of the implant procedure that involves the use of collagen membranes. Periodontal diseases, dental caries, and tooth losses are much more prevalent in the geriatric population because of cumulative age effects, side effects of medication that inhibit saliva production and such systemic conditions as diabetes and cardiovascular disease.

Dental health statistics suggest that the average age at which one needs dentures is 40-49 years in the U.S., and most of the patients then seek a more stable and comfortable option using implants. Tooth loss results in pain in eating and speaking, alteration in the looks of the face due to bone resorption, and the resulting gradual loss of the alveolar bones that leaves clinical evidence of regenerative surgeries to restore bone volume and provide support to implant placement. The global dentures, implants, and oral prosthetics business is witnessing a significant expansion, which is projected to grow from USD 12.57 billion in 2025 to USD 18.79 billion in 2030, the growth of which is also due to ageing.

The elderly patients are more concerned about the enhancement of quality of life with the help of high-level dental treatment, disposable income and healthcare insurance are encouraging the increased investments in the implant procedures with the use of collagen membranes. The concept of modern regenerative dentistry allows seniors to preserve their oral functions and facial appearance by means of bone grafting and placing implants and using collagen membranes as a mandatory element that guarantees the success of the procedure. The demographic changes, increased awareness of treatment options, increased healthcare access, and success rates of clinical treatment provide a long-term demand on dental collagen membranes in maintaining oral health in the geriatric population.

What are the Major Advances Changing the Dental Collagen Membranes Market Today

• Cross-Linked and Engineered Collagen Membrane Technologies:

The most disruptive technological change is the creation of cross-linked collagen membranes with improved degradation control and mechanical strength that allows for achieving a longer barrier functional period, better handling properties, and shorter regeneration periods that can be adjusted to specific clinical need variations. Conventional non-cross-linked collagen membranes normally resorb in 4-8 weeks but this is not enough in guided tissue regeneration efforts but in guided bone regeneration procedures where longer barrier activity is necessary to permit full bone development.

The cross-linked collagen membranes are cross-linked using chemical or enzymatic cross-linking to extend the functional barrier time to 4-6 months or longer according to the degree of cross-linking. Clinical studies show that the cross-linked membranes have 40-60 slower rates of resorption in comparison to the non-cross-linked ones, which offers long-term exclusion of epithelial and connective tissues to the bone defects at the cost of biocompatibility. The sophisticated cross-linking methods such as riboflavin-mediated photochemical cross-linking, glutaraldehyde treatment and natural crosslinkers such as genipin generate a product portfolio with diverse clinical applications. Bilayer designs are incorporated into engineered collagen membranes, with fast-resorbing layers in direct contact with soft tissue and slower-resorbing layers in direct contact with bone, to achieve the most effective results in regeneration by tissue-specific degradation kinetics. Other hi-tech membranes incorporate bioactive elements such as growth factors, antibiotics or platelet concentrates to improve osteogenic property and minimize the risk of infections.

The industry statistics reveal cross-linked membrane segments to have a fast adoption with a CAGR of more than 8% due to the excellent clinical performance in complex regenerative applications, such as large defects, placement of implants immediately, and impaired healing conditions. The pore size, thickness, and tensile strength of membranes can be controlled accurately using modern manufacturing procedures and produce membranes that are ideally suited to the anatomical location and the procedure itself. The technological advances have extended clinical indications of the conventional periodontal regeneration to complex ridge augmentation, sinus floor elevation, treatment of peri-implantitis, and socket preservation, greatly increasing the market opportunities.

• Biomimetic and Composite Membrane Systems:

The combined application of biomimetic design principles and composite material systems responds to the needs of the dental profession in terms of increased handling properties, better space maintenance and increased bone formation through bioactive functionalization. Although pure collagen membranes are more biocompatible, they are not always rigid enough to provide space in large defects or in regions exposed to tissue pressure in a healing process. Composite membranes are made of collagen with synthetic polymers such as polylactic acid, polyglycolic acid or polycaprolactone producing materials with different mechanical characteristics and degradation characteristics. Based on the research in materials science, composite designs show a 2-3 fold increased tensile strength compared to pure collagen without loss of biocompatibility and cell-occlusive qualities needed in guided regeneration.

Biomimetic membranes are fabricated using natural extracellular matrix architecture by using specialized cell processing such as electrospinning where nanofibrous membranes are formed that improve cell adhesion, growth, and differentiation of osteoprogenitor cells. Other sophisticated products use calcium phosphate particles, hydroxyapatite crystals, or bioactive glass in collagen matrices and these have osteoinductive and osteoconductive characteristics that stimulate bone formation. Clinical trials have shown biomimetic membranes have an average healing time that is 20-30% shorter than the traditional collagen membrane with the same or better bone fill in bone regeneration.

The use of antimicrobial agents such as silver nanoparticles, chlorhexidine, or naturally derived antimicrobials overcomes postoperative infection issues and it is essential in immunocompromised individuals or contaminated areas. The most recent product examples represent the innovation trends, such as the introduction of membranes with gradient porosity, asymmetric design with the creation of directional tissue guidance, and smart materials with responses to local biochemical concentrations. Such composite and biomimetic systems allow minimal invasiveness and shorter surgical operations due to better handling and predictability of regenerative performance, which leads to increasing use and market growth by clinicians.

• Standardized and Application-Specific Membrane Formats:

The introduction of pre-shaped, anatomically shaped, and procedure-specific collagen membrane formats fills the clinical requirement of simplified surgical procedures, decreased chair time, and enhanced efficiency of the procedure in hectic dentistry practices. Conventional collagen membranes had to be trimmed and contoured in place to fit certain geometries of defects, which took precious surgical time as well as potentially compromising the integrity of the membrane by overhandling it. Pre-shaped membranes available in modern practice apply in common clinical environments such as single-tooth extraction sockets, molar extraction sites, sinusoidally augmented areas, and anterior aesthetic areas and can be placed quickly and with optimum defect coverage.

The dental practice management data indicates that pre-shaped membranes will save 30-40% of the time used to put up membranes compared to placing free trimming which makes surgery more efficient in high-volume practice. Other products are highly developed and have an integrated fixation system such as resorbable pins or tacks in the shape of a membrane periphery, which do not require additional fixation steps to be performed and further simplify processes. Membrane kit Application-specific membrane kits ship complementary bone grafting plastic with appropriately sized membranes, surgical equipment, and fixatives into one package, forming a complete regenerative solution that is easy to store and maintain inventory. This means that the less experienced practitioners can reach similar consequences as those of a specialist, which is made democratically available to regenerative processes and has penetrated a significant portion of the market that is usually regulated by specialty practices to general dentistry through the standardization.

Digital dentistry with CBCT-based surgical planning allows personalized membrane production of the geometry of defects and individual anatomies with some manufacturers producing 3D-printed or digitally cut collagen membranes that fit the shape of the anatomy exactly. These novelties include the accuracy needs of immediate implant placement and full-arch rehabilitation as well as intricate aesthetic cases that need reliable soft tissue shapes. The analysis of the industry shows that the market growth rate of application specific and ready-built membrane sections is in the double-digit range as dental practices focus on workflow optimization and predictability of outcomes in addition to clinical performance.

• Enhanced Biocompatibility Through Advanced Sourcing and Processing:

A rise in attention to biocompatibility, safety and patient acceptance has led to increased complexity of collagen sourcing and processing technologies that avoid immunogenic constituents, enhance tissue incorporation and increase the range of acceptable biomaterial sources such as marine and recombinant sources. Bovine and porcine membranes are traditional types of collagen membrane that sometimes provoke an immune response in some patients or have a barrier of religious and cultural acceptance in some populations.

The purification processes which include multi-step enzymatic digestion, chemical extraction, and terminal sterilization of the product eliminate the telopeptides and other antigenic constituents that cause immune reactions producing highly purified collagen with excellent biocompatibility profiles. Immunological research results suggest that current purified collagen membranes have a lower adverse reaction rate of less than 2% than the previous-generation products' 8-10%, meaning that patient safety is greatly enhanced and the number of suitable candidates is increased. Certain manufacturers have come up with marine-based collagen membranes derived from fish skin and fish scales that can be used as alternatives for patients with mammalian protein allergies or with religious dietary limitations.

The marine collagen has shown similar biocompatibility and regenerative properties as those of mammalian sources and offers differentiated product positioning. Recombinant human collagen made under biotechnology conditions is a new frontier, which may have perfect biocompatibility, an indefinitely scalable supply, and no zoonotic disease transmission issues, but now it is faced by the economic difficulties that restrict commercial feasibility. Higher level processing methods such as supercritical CO₂ sterilization, gamma irradiation and electron beam treatment eliminate pathogens but do not disrupt the collagen structure or bioactivity as compared to conventional autoclave sterilization. These enhancements tackle regulatory demands in the healthcare sector, concerns about patient safety, and quality assurance needs, which will sustain market expansion and clinical implementation in a wide range of patient groups and geographical market segments.

Category Wise Insights

By Source

Why Bovine Collagen Leads the Market?

The largest segment is carried by bovine-derived collagen membranes which will capture about 62% of the total market share in 2025. This prevalence is in line with the long history of the clinical track record of bovine collagen, good cost-effectiveness, wide availability, and well-defined biocompatibility that make it the dentist's regenerative procedure of choice in most countries worldwide. The use of bovine collagen in clinical dentistry is more than 4 decades old and is reported to have safety and efficacy data spanning millions of cases all over the world. The source of bovine collagen is mainly in bovine dermis and pericardium tissues, which have high-purity type I and type III collagen fibers that are ideal in the manufacture of membranes. Such membranes are made of natural collagen matrix supports cell adhesion, proliferation, and differentiation of periodontal ligament cells, cementoblasts, and osteoblasts needed to achieve regenerative success.

Porcine collagen membrane is an emerging market segment that is being propelled by high biocompatibility, structural properties that are comparable to human collagen, and acceptance in markets where bovine sources have been a subject of religious or cultural issues. Comparing porcine-based membranes to bovine-based ones, the membranes of porcine have superior resorption characteristics than those of bovine choice and are thus better options in guided tissue regeneration and socket preservation tasks that demand shorter barrier function time frames. Porcine collagen membranes have a 20-30% higher degradation rate than bovine counterparts when processing conditions are held constant as per biomaterials analysis, and allows clinicians an expanded range of choices to match membrane with healing rates.

By Type

Why Resorbable Membranes Dominate Applications?

Resorbable collagen membranes constitute the major segment with an overall market share of about 89% in 2025. Such dominating leadership is a response to the core clinical benefit of not having to undergo secondary surgical operations to remove the membranes which will greatly enhance patient care at a much lower cost of treatment and complication risk. Membranes that can be resorbed naturally, via enzymatic and hydrolytic mechanisms, are absorbed by the body during a predefined period of time, which can be several weeks to several months in relation to the cross-linking intensity and membrane structure. Resorbable segment is showing the quickest growth with an expected CAGR of 7.8% in the coming five years (2026-2035) owing to the increasing clinical use, better material technologies, and increasing patient preference for less invasive procedures.

Clinical results of modern resorbable membranes are the same or better than non-resorbable ones in most indications. Clinical trials involving resorbable collagen versus ePTFE membranes in periodontal regeneration report statistically non-significant clinical improvement in terms of periodontal attachment gain, reduction of probing depth and bone fill, and in patient-reported outcomes, some studies report minor advantages of the collagen membranes. The resorbable membrane is under the segment of non-cross-linked and cross-linked and both have their own clinical benefits. Non-cross-linked membranes offer a fast resorption between 4 and 8 weeks, which is ideal in guided tissue regeneration in the presence of natural teeth as well as socket maintenance after extraction. Cross-linked membranes increase the period of barrier to 4-6 months, which is suitable in guided bone regeneration to support the implant placement and large defects that need long-space maintenance. Based on market research, the cross-linked membrane sub-segment has been recording a very strong growth rate of 8.3% CAGR, which has been supported by the growing number of implant surgeries and challenging regenerative cases.

By Application

Why Guided Bone Regeneration Dominates Collagen Membrane Applications?

Applications of guided bone regeneration (GBR) constitute the greatest market share, with a contribution of about 44% of the total market share in 2025. This leadership can be summed up by the fact that bone augmentation is a core procedure in contemporary implant dentistry in which there must be sufficient bone volume so that the implant placement is successful with long-term stability. GBR processes involve the use of barrier membranes to isolate bone defects of epithelial and connective tissues to provide environments in which osteogenic cells present in the adjacent bone may expand and generate new bone. The standard bone size that should be covered by implant surfaces in order to achieve successful long-term results in terms of some kind of implant is 1-1.5mm. Statistically, around 40-50% of the places of implantation need some type of bone augmentation because the native bone volume is inadequate as a result of past extractions, periodontal disease, or anatomical constraints.

The applications with the highest growth rate are Ridge preservation applications with a projected CAGR of 8.6% between 2026 and 2035, which will be due to a shift to proactive socket management immediately after extraction as opposed to reactive augmentation before an implant is placed. Ridge preservation is a procedure that involves inserting bone graft materials and collagen membranes in fresh extraction sockets, which reduces the alveolar bone resorption, which is otherwise experienced after removal of teeth. Research shows that unrestored extraction sites lose 40-60% of original bone volume in the first year, most of which is lost in the first 3-6 months. The socket preservation studies have shown that grafted sockets with membrane covers maintain 90-95% of original dimensions to significantly enhance the options of implantation placement and to eliminate the necessity of complicated augmentation procedures. The increasing focus on instant and early implant placement guidelines, enhanced knowledge of the extraction socket recovery biology, and the financial advantages of proactive preservation in comparison to reactive augmentation promote the quick segment growth.

By End-User

Why Dental Clinics Dominate the Market?

The largest segment of the end-user would be dental clinics which will have a market share of about 56% in 2025. This hegemony indicates the procedural fact that most dental implant dentures, periodontal regeneration surgeries, and bone augmentation surgeries are carried out in private dental facilities and specialty clinics as opposed to hospitals. The segment related to dental clinics involves the general dentistry practices that offer the basic regenerative procedures, periodontal specialty practices, which involve the treatment of gum disease and soft tissue regeneration, oral surgery and implantology practices, which involve the study of complex bone augmentation and implant placement, and the prosthodontic practices, which involve the provision of comprehensive oral rehabilitation.

The dental practice statistics indicate that around 32.8% of the general dentists install dental implants surgically with ages far higher among periodontists and oral surgeons, which provides a wide market for collagen membranes among the types of practices.

The dental clinics also enjoy direct contacts with dental supply distributors and sales representatives of the manufacturers ensuring the availability of the products, clinical education, and technical support to enable the adoption of collagen membrane. According to the industry statistics, dental clinics still use collagen membranes at a much higher rate than that of hospitals on a per-procedure basis because of higher volumes of procedures and regular inclusion of the implant and periodontal procedures into practices. The current direction of dental service organizations (DSOs) and group practices provides purchasing power benefits and uniformity in clinical protocols that favor and encourage the consistent use of collagen membranes in various sites of practice.

Report Scope

Regional Analysis

How Big is the North America Market Size?

The North America dental collagen membranes market size is estimated at USD 164 million in 2025 and is projected to reach approximately USD 287 million by 2035, with a 6.7% CAGR from 2026 to 2035.

Why did North America Dominate the Market in 2025?

The most significant player in the world is North America, which will have an approximate market share of 38% in the year 2025 due to the excellent dental care infrastructure, high rates of dental implant penetration, good insurance coverage of dental care, well-developed specialist training systems, and a well-established regenerative dental implant adoption. The area enjoys the benefits of an internationally recognized dental education that results in well-trained practitioners, strong research and development that leads to innovation, good reimbursement policies that assist in promoting high-technology procedures, patient awareness and acceptance of the regenerative therapies. The United States controlled the market with a dominating share based on the fact that it is the largest market for dental services in the world, having more than 200,000 dentists practicing and about 3 million dental implants a year.

United States Market Trends

The market in the US is the largest in the world, with the highest levels of dental implant placement in the world with 3 million dental implant procedures being placed every year and increasing, well-developed periodontal specialty care infrastructure with more than 5,500 board-certified periodontists, robust private insurance coverage to fund regenerative dental procedures and large clinical research to establish evidence-based guidelines. In the analysis of the dental industry, it was found that there are about 178 million Americans who are missing one or more teeth, and 40 million Americans are totally edentulous and this forms a colossal potential market for the implant procedures necessitating collagen membranes. Aging Baby Boomer population (73 million in number) that has reached retirement age in good health and financial standing is one of the key demographics that can lead to the expansion of implant and regenerative procedures. Also, the U.S. market enjoys the FDA regulatory paths that demonstrate product safety and effectiveness, which establish confidence among the clinicians in the approved biomaterials.

Why is Europe Experiencing Steady Growth?

Europe has a stable growth with a predicted CAGR of 7.3% between 2026 and 2035, as a result of well-established dental care systems, high priorities on preventive and regenerative care systems, extensive public and private insurance facilities, and well-developed clinical research resources. The European market is also huge in terms of representing high standards of dental education, rigid regulation requirements in the form of CE marking, cultural disposition toward tooth replacement, and the aging aged population that consumes dental replacement. The European region also has a strong global market share with Germany, France, the United Kingdom, Italy, and Spain as the main markets. The European dental statistics indicate that the region carries out more than 4 million dental implant surgeries yearly with consistent growth patterns.

Germany Market Trends

Germany boasts the largest European market base with world standard dental training and education, universal coverage of dental benefits under the healthcare system, a high level of awareness and acceptance of treatment among the patients, high potential in manufacturing dental biomaterials, and effective clinical research facilities. Europe is at the forefront in the use of regenerative procedures through the German dental practices which are aided by good insurance reimbursement on medically required procedures. Quality and evidence-based care are highly valued in the German market, which leads to the creation of a demand in favor of high-quality collagen membranes with a rich clinical history. Large universities and research centers in Germany play a significant role in the development of collagen membranes and their clinical validation.

Why is Asia Pacific Experiencing Rapid Growth?

With fast population growth with a projected CAGR of 8.2% in 2026-2035, growing and large populations, rising disposable incomes to purchase dental care, improving healthcare infrastructures, growing dental awareness and oral hygiene priorities, and a rising dental tourism sector, the Asia Pacific region is expected to experience rapid growth. The area has positive demographic factors such as urbanization which has led to the creation of dental services demand, the growth of the middle class with the purchasing power of healthcare and the aging population which needs restorative dental services. The markets of China and India are specifically dynamic with huge populations, the fast-growing dental industries and the state allocation of healthcare investments.

China Market Trends

The growing population of 1.4 billion people with increasing dental care concerns, the increasing number of middle classes with more than 400 million people with discretionary healthcare spending, healthcare reforms by the government that increased the coverage of dental care and the massive expansion of the private dental clinic and specialty practices have helped China to have the fastest-growing dental collagen membranes market in the Asian Pacific. Below is an example of statistics of the Chinese dental industry that shows that the country has been undertaking more than 2 million dental implant surgeries each year with growth rates of 10 digits. Chinese dental schools are graduating thousands of new dentists by the year, with a lot of them having advanced training in implantology and periodontics with the inclusion of collagen membrane use. The government of China has a program known as Healthy China 2030 which focuses on oral health and promotes market growth.

Top Players in the Market

• Geistlich Pharma AG 

• Zimmer Biomet Holdings Inc. (ZimVie) 

• Integra LifeSciences Corporation 

• Dentsply Sirona 

• Institut Straumann AG 

• BioHorizons IPH Inc. 

• Collagen Matrix Inc. 

• Sunstar Americas Inc. 

• Botiss Biomaterials GmbH 

• ACE Surgical Supply Co. Inc. 

• Others

Key Developments

The market has undergone significant developments as industry participants seek to expand capabilities and enhance product portfolios.

• In August 2025: Geistlich Pharma has stated that it is partnering with Stryker to co-develop and co-market the next generation of collagen barrier membranes used in regenerating the mouth. This is aimed at expanding international access and achieving uniformity in all markets to show the current pattern of consolidation and cooperation in the industry.

• In January 2025: RTI Surgical (RTI or the Company), the industry-leading CDMO in the vanguard of innovation and tissue engineering in regenerative medicine, announced that it had successfully acquired Collagen Solutions.

These strategic activities have allowed companies to strengthen market positions, expand product offerings, enhance technological capabilities, and capitalize on growth opportunities within the expanding market.

The Dental Collagen Membranes Market is segmented as follows:

By Source

• Bovine Collagen

• Porcine Collagen

• Marine Collagen

• Other Sources

By Type

• Resorbable Membranes

o   Non-Cross-Linked Membranes

o   Cross-Linked Membranes

• Non-Resorbable Membranes

o   ePTFE Membranes

o   d-PTFE Membranes

By Application

• Guided Bone Regeneration (GBR)

• Guided Tissue Regeneration (GTR)

• Ridge Preservation

• Periodontal Regeneration

• Implant Dehiscence Coverage

• Other Applications

By End-User

• Dental Clinics

• Hospitals

• Ambulatory Surgical Centers

• Academic & Research Institutes

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America